Note on the controlled trials that could not be included in meta-analyses Because they did not report incidences consistent with those of the studies included in the metaanalyses, four controlled trials could not be included in meta-analyses but were consistent with meta-analysis findings.
Johnson et al. conducted a double-blind, placebo-controlled cross-over study in 56 children with neurogenic bladders and found a lower proportion of infection in the nitrofurantoin group (19%) compared with the placebo group (39%) (p<0.003) [1] .
Lohr et al. found significantly fewer bacteriuria episodes in children receiving prophylactic nitrofurantoin compared to those receiving placebo [2] .
In the third study comparing nitrofurantoin to methenamine hippurate, trimethoprim, and trimethoprim/sulfamethoxazole yielded a favourable outcome for nitrofurantoin in comparison with methenamine hippurate (3.8 and 4.7 recurrences per treatment month, respectively) [3] . The results in the meta-analysis on trimethoprim and trimethoprim/sulfamethoxazole were not all in agreement, but this study supports the favourable outcome of both trimethoprim and trimethoprim/sulfamethoxazole (1.5 and 2.3 recurrences per treatment-month, respectively) compared to nitrofurantoin (3.8 recurrences per treatment-month) [3] .
A controlled trial in the elderly compared nitrofurantoin, methanamine hippurate and no therapy [4] . Though specific ages were not reported, patients were "elderly" and had either urinary incontinence or retention associated with a cerebrovascular disorder. In the control group (no therapy) received almost twice as many antibiotic courses as the other groups, confirming the results of the metaanalyses for an effect of nitrofurantoin over placebo [4] . This is important since nitrofurantoin's use in the elderly has been discouraged [5] , because the drug is excreted by the kidneys and its clinical effect dependent on urinary concentrations. *Unspecified chest pain N=28, painful respiration N=3, pleural effusion N=1 **DILI: Drug-induced liver injury *** this databases includes AE from available publications, drug regulatory authorities, case reports of studies sponsored by that company and from information submitted to the company from any other source, worldwide since nitrofurantoin's introduction in 1953. NF: nitrofurantoin; AHSM: Agence nationale du medicament et des produits de la santé; n.a.: not available; AE: adverse event; CI: confidence interval
